comprehensive -WSS

comprehensive

author：comprehensive 2025-08-25 05:56:26 - browse：75124

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： A look at other Americans who have crossed into North Korea over the years

WSS

Study: Hearing aids may slow cognitive decline in those at risk

More hospitals are billing patients as online messages surge

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Study: Hearing aids may slow cognitive decline in those at risk

'Little Tech' descents on D.C., wanting a say in how AI is regulated

focus

comprehensive

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Robert Kennedy Jr.'s presidential campaign attracts GOP

Novavax promises a turnaround & Lilly roils the obesity market

Manchin plays down potential 3rd

Walensky prepares to leave CDC — and Congress — behind

Congress needs to close a vaccine

As demand for Covid shots wanes, Moderna seeks its next success

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

State Dept. review finds Biden bears some blame for Afghanistan failures

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

hotspot

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

UnitedHealth CEO's Medicaid comments send insurer stocks diving

FDA approves Moderna’s RSV vaccine, its second licensed product

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

A Theranos scientist

hotspot

leisure time

hotspot

focus